June 2021
Volume 62, Issue 8
Open Access
ARVO Annual Meeting Abstract  |   June 2021
Retinal neuroinflammation in an ALS mouse model (SOD1G93A)
Author Affiliations & Notes
  • Pilar Rojas
    Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid Facultad de Medicina, Madrid, Comunidad de Madrid, Spain
    Ophthalmology, Hospital General Universitario Gregorio Maranon, Madrid, Madrid, Spain
  • Manuel Cadena
    Ophthalmology, Hospital General Universitario Gregorio Maranon, Madrid, Madrid, Spain
  • José A. Fernández-Albarral
    Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid Facultad de Medicina, Madrid, Comunidad de Madrid, Spain
  • Inés López Cuenca
    Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid Facultad de Medicina, Madrid, Comunidad de Madrid, Spain
  • Elena Salobrar-García
    Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid Facultad de Medicina, Madrid, Comunidad de Madrid, Spain
    Departamento de Inmunología, Oftalmología y ORL, Universidad Complutense de Madrid Facultad de Optica y Optometria, Madrid, Comunidad de Madrid, Spain
  • Rosa de Hoz
    Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid Facultad de Medicina, Madrid, Comunidad de Madrid, Spain
    Departamento de Inmunología, Oftalmología y ORL, Universidad Complutense de Madrid Facultad de Medicina, Madrid, Comunidad de Madrid, Spain
  • Juan J. Salazar
    Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid Facultad de Medicina, Madrid, Comunidad de Madrid, Spain
    Departamento de Inmunología, Oftalmología y ORL, Universidad Complutense de Madrid Facultad de Optica y Optometria, Madrid, Comunidad de Madrid, Spain
  • José L. Urcelay
    Ophthalmology, Hospital General Universitario Gregorio Maranon, Madrid, Madrid, Spain
    Departamento de Inmunología, Oftalmología y ORL, Universidad Complutense de Madrid Facultad de Medicina, Madrid, Comunidad de Madrid, Spain
  • Irene Santos
    Instituto Universitario de Investigación en Neuroquímica, Departamento de Bioquímica y Biología Molecular, Universidad Complutense de Madrid Facultad de Medicina, Madrid, Comunidad de Madrid, Spain
    Centro de Investigación Biomédica en Red de Enfermedades Neuroegenerativas (CIBERNED) and Instituto Ramón y Cajal de investigación Sanitaria (IRYCIS), Madrid, Madrid, Spain
  • Eva Lago
    Instituto Universitario de Investigación en Neuroquímica, Departamento de Bioquímica y Biología Molecular, Universidad Complutense de Madrid Facultad de Medicina, Madrid, Comunidad de Madrid, Spain
    Centro de Investigación Biomédica en Red de Enfermedades Neuroegenerativas (CIBERNED) and Instituto Ramón y Cajal de investigación Sanitaria (IRYCIS), Madrid, Madrid, Spain
  • Jose Ramirez
    Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid Facultad de Medicina, Madrid, Comunidad de Madrid, Spain
    Departamento de Inmunología, Oftalmología y ORL, Universidad Complutense de Madrid Facultad de Medicina, Madrid, Comunidad de Madrid, Spain
  • Ana Ramirez
    Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid Facultad de Medicina, Madrid, Comunidad de Madrid, Spain
    Departamento de Inmunología, Oftalmología y ORL, Universidad Complutense de Madrid Facultad de Optica y Optometria, Madrid, Comunidad de Madrid, Spain
  • Footnotes
    Commercial Relationships   Pilar Rojas, None; Manuel Cadena, None; José A. Fernández-Albarral, None; Inés López Cuenca, None; Elena Salobrar-García, None; Rosa de Hoz, None; Juan J. Salazar, None; José Urcelay, None; Irene Santos, None; Eva Lago, None; Jose Ramirez, None; Ana Ramirez, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science June 2021, Vol.62, 3047. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Pilar Rojas, Manuel Cadena, José A. Fernández-Albarral, Inés López Cuenca, Elena Salobrar-García, Rosa de Hoz, Juan J. Salazar, José L. Urcelay, Irene Santos, Eva Lago, Jose Ramirez, Ana Ramirez; Retinal neuroinflammation in an ALS mouse model (SOD1G93A). Invest. Ophthalmol. Vis. Sci. 2021;62(8):3047.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : To determine the differences in retinal microglial and ganglion cell behaviour in a SOD1G93A mouse model (SOD) of amyotrophic lateral sclerosis (ALS) compared to the wild type (WT).

Methods : In retinal whole-mounts labelled with anti-Iba-1 (microglial marker) from two experimental groups WT (n=6) and SOD ALS (n=6), were quantified the number of retinal ganglion cells (RGCs) Brn3a+ and the signs of microglial activation in different retinal layers: i) Iba-1 + cells number in outer segments (OS), outer plexiform layer (OPL) and inner complex layer (ICL) constituted by inner plexiform layer (IPL), ganglion cell layer (GCL) and retinal nerve fiber layer (RNFL); ii) area occupied by Iba-1+ cells in OPL and IPL; and iii) arbor area of Iba-1+ cells in OPL and IPL. In addition, the expression of anti- IFN-γ and anti-IL-1β (pro-inflammatory M1 phenotype) and anti-arginase-I and anti-IL-10 (anti-inflammatory M2 phenotype) were analysed. Animals were sacrificed with 120 days old (advanced stage of the disease).

Results : Compared to WT, the retina of SOD1 ALS mice showed: i) Migrations and reorientation processes of some Iba-1 + cells; ii) a significant increase in the area occupied by each microglial cell in the total area of the retina; ii) a significant increase in arbor area in the outer plexiform layer (OPL) inferior sector; iii) presence of cells with retracted processes; iv) areas of cell groupings in some sectors; v) no significant increase in the number of microglial cells, vi) expression of IFN-γ and IL-1β; vii) non-expression of IL-10 and arginase-I; v) A decrease in number of RGCs.

Conclusions : In the SOD1G93A ALS model at 120 days (advanced stage of the disease), retinal microglial activation occurs, taking a pro-inflammatory M1 phenotype, which affected OPL and inner retinal layers and could be related to the RGCs loss. Although ALS is a disease of motor neurons, it can also affect retinal tissue, where an inflammatory process and death of retinal neurons occurs.

This is a 2021 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×